Produced by AVE, it is a new serial of product with machine vision technology, low power screening, positioning, and high-power tracking recognition.

Stay up-to-date with the latest happenings in the rapidly evolving field of In Vitro Diagnostics (IVD) in China.

On April 13, National Medical Products Administrations (NMPA) reviewed and approved Zhuhai Livzon Diagnostics Inc. and Shanghai BioGerm Medical Technology Co., Ltd's COVID-19 Antigen Test.

The US Food and Drug Administration last week granted separate Emergency Use Authorizations for a PCR-based SARS-CoV-2 test developed by the University of California, San Diego and an at-home nasal specimen collection kit from the Washington D.C. Department of Health.

Medical advances are causing a gradual increase in average life expectancy. However, this comes at a price, as the number of cases of dementia and other neurodegenerative diseases grows with age.

CLS.CN reported on April 12 that Andon Health announced that the net profit in the first quarter is expected to be CNY 14 billion to CNY 16 billion, a year-on-year increase of 36707.43% to 41965.63%.

ECDC and EMA have concluded that it is too early to consider using a fourth dose of mRNA COVID-19 vaccines in the general population.

The US Food and Drug Administration this week granted separate Emergency Use Authorizations for over-the-counter SARS-CoV-2 antigen self-tests developed by Osang Healthcare.

A few days ago, the Department of Planning, Development and Information Technology of the China National Health and Medical Commission issued the "Notice of the Office of the Healthy China Action Promotion Committee on Printing and Distributing the Work Points of the Healthy China Action in 2022".

Quidel on Thursday said that it expects its first quarter revenues to nearly triple year over year, primarily on sales of COVID-19 testing products.

The scientists, led by Joseph Vinetz, MD, an infectious diseases specialist, were interested to find out if an oral medication used to treat pancreatitis could reduce the viral load (the amount of virus in your body) of SARS-CoV-2 and improve symptoms in people newly diagnosed with COVID-19.

The Biden-Harris Administration announced on April 4 that more than 59 million Americans with Medicare Part B, including those enrolled in a Medicare Advantage plan, now have access to Food and Drug Administration (FDA) approved, authorized, or cleared OTC COVID-19 tests at no cost.